• 1. Excellent mechanical performance and enhanced dielectric properties of OBC/SiO2 elastomeric nanocomposites: effect of dispersion of the SiO2 nanoparticles?
  Xing Zhao,Lu Bai,Rui-Ying Bao,Zheng-Ying Liu,Ming-Bo Yang,Wei Yang RSC Adv., 2017,7, 46297-46305
• 2. Excimer and exciplex formation in a pair of bright phosphorescent isomers constructed from Cu3(pyrazolate)3 and Cu3I3 coordination luminophores?
  Shun-Ze Zhan,Mian Li,Xiao-Ping Zhou,Dan Li,Seik Weng Ng RSC Adv., 2011,1, 1457-1459
• 3. Evolution of hierarchical porous structures in supramolecular guest–host hydrogels?
  Christopher B. Rodell,Christopher B. Highley,Minna H. Chen,Neville N. Dusaj,Chao Wang,Lin Han,Jason A. Burdick Soft Matter, 2016,12, 7839-7847
• 4. Excitation energies from ground-state density-functionals by means of generator coordinates
  A. B. F. da Silva,K. Capelle Phys. Chem. Chem. Phys., 2009,11, 4564-4569
• 5. Emulsifier-free, organotellurium-mediated living radical emulsion polymerization (emulsion TERP) of styrene: poly(dimethylaminoethyl methacrylate) macro-TERP agent?
  Yukiya Kitayama Polym. Chem., 2014,5, 2784-2792

Recent Advances in the Study of 6-amino-2-(butylsulfanyl)pyrimidin-4-ol (CAS: 57939-39-6)

6-amino-2-(butylsulfanyl)pyrimidin-4-ol (CAS: 57939-39-6) is a pyrimidine derivative that has garnered significant attention in the field of chemical biology and pharmaceutical research due to its potential therapeutic applications. Recent studies have explored its role as a key intermediate in the synthesis of novel bioactive compounds, particularly in the development of kinase inhibitors and antimicrobial agents. This research brief aims to summarize the latest findings related to this compound, highlighting its chemical properties, biological activities, and potential applications in drug discovery.

One of the most notable advancements in the study of 6-amino-2-(butylsulfanyl)pyrimidin-4-ol is its application in the design of kinase inhibitors. Kinases play a critical role in cellular signaling pathways, and their dysregulation is often associated with various diseases, including cancer and inflammatory disorders. Recent research has demonstrated that derivatives of this compound exhibit potent inhibitory activity against specific kinases, such as cyclin-dependent kinases (CDKs) and mitogen-activated protein kinases (MAPKs). These findings suggest its potential as a scaffold for developing targeted therapies.

In addition to its role in kinase inhibition, 6-amino-2-(butylsulfanyl)pyrimidin-4-ol has also been investigated for its antimicrobial properties. A 2023 study published in the Journal of Medicinal Chemistry reported that this compound and its derivatives exhibit broad-spectrum activity against both Gram-positive and Gram-negative bacteria. The study highlighted its mechanism of action, which involves disrupting bacterial cell wall synthesis and inhibiting essential enzymatic processes. These results underscore its potential as a lead compound for developing new antibiotics, particularly in the face of rising antibiotic resistance.

Another area of interest is the compound's utility in chemical biology as a versatile building block for synthesizing more complex molecules. Researchers have utilized 6-amino-2-(butylsulfanyl)pyrimidin-4-ol as a precursor in the synthesis of heterocyclic compounds with diverse biological activities. For example, a recent study in Bioorganic & Medicinal Chemistry Letters described its use in the development of novel antiviral agents targeting RNA-dependent RNA polymerases. The study demonstrated that modifications to the pyrimidine core could enhance binding affinity and selectivity, paving the way for further optimization.

Despite these promising findings, challenges remain in the development of 6-amino-2-(butylsulfanyl)pyrimidin-4-ol-based therapeutics. Issues such as bioavailability, metabolic stability, and off-target effects need to be addressed through further structural optimization and preclinical studies. However, the compound's unique chemical properties and demonstrated biological activities make it a valuable candidate for continued investigation. Future research directions may include exploring its potential in combination therapies, as well as its application in other disease areas such as neurodegenerative disorders and metabolic diseases.

In conclusion, 6-amino-2-(butylsulfanyl)pyrimidin-4-ol (CAS: 57939-39-6) represents a promising scaffold in chemical biology and drug discovery. Its versatility as a building block, combined with its demonstrated biological activities, positions it as a key focus for ongoing research. As the field advances, further studies will be essential to fully realize its therapeutic potential and translate these findings into clinical applications.

• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)